Introduction
Glycosylation is one of the most important modifications in nature, as it plays an essential role in the biological activity, specificity, and stability, as well as the pharmacokinetics of many natural products [1] [2] [3] . Glycosyltransferases (GTs), natural enzyme tools for glycan construction, have attracted growing interest, owing to their high efficiency and regioselectivity in synthetic glycochemistry [4] [5] [6] . However, enzyme glycosylation is normally restricted by the verification of suitable GTs for the target compounds [7] . Thus, mining GTs with aglycon promiscuity is an important route to generate diverse, bioactive, glycosylated natural/unnatural products.
In recent years, GTs from microbes have been reported to be a rich source for efficient glycol-transformation of both natural and unnatural compounds [8] [9] [10] [11] . In our previous study, we identified and characterized the bmmGT1 gene from marine-derived Bacillus methylotrophicus B-9987 (CGMCC No. 2095), which encodes a protein responsible for the glycosylation of macrolactins (24-membered macrolides) and bacillaenes (polyunsaturated enamines) [12] [13] [14] . BmmGT1 exhibited flexible substrate specificity with regard to different aglycons (macrolactin A, malonyl-macrolactin A, and succinyl-macrolactin A) or/and sugar donors (UDP-D-glucose and UDP-D-N-acetylglucosamine). In our continuous study to explore the catalytic capability and potential application of BmmGT1 in compound diversification, the reaction conditions and substrate promiscuity of BmmGT1 were further probed herein. A series of Oglycosylated macrolactins (1a-1e) were thus generated ( Fig. 1) , among which two (1b and 1e) were identified as new compounds. Interestingly, BmmGT1 catalyzed the attachment of sugars to the thiol (S-) or amine (N-) sites of phenolic aglycons (2 and 3), which generated two known (2a and 3a) analogs and one new (3b) one. These results demonstrated that BmmGT1 is not only able to serve as an O-GT, but as a S-GT and N-GT as well.
Materials and Methods

Experimental
1D and 2D NMR spectra were recorded on Bruker Avance III 600 spectrometers. Chemical shifts were reported with reference to the respective solvent peaks and residual solvent peaks (δ H 2.50 and δ C 39.5 ppm for DMSO-d 6 ). HR-ESIMS data were obtained on a Q-TOF Ultima Global GAA076 LC-MS spectrometer. HPLC was performed on an Agilent 1260 Infinity equipment with diode array detector. The reagent UDP-D-glucose was purchased from Sigma-Aldrich Company, and 3,4-dichloroaniline (2) and 3,4-dichlorobenzenethiophenol (3) were purchased from Shanghai Energy Chemical Company (China).
Bacterial Strains and Culture Conditions
Escherichia coli BL21 (DE3) was used as a host for protein expression. E. coli strains and Bacillus strains were routinely cultured in Luria-Bertani (LB) liquid medium at 37°C and 200 rpm, or on LB agar plates at 37°C. When appropriate, kanamycin (s100 μg/ml for E. coli) or erythromycin (5 μg/ml for Bacillus) was added to the medium.
Heterologous Expression and Purification of BmmGT1
The pWLI206 plasmid harboring the bmmGT1 gene was constructed previously [13] . Expression of the recombinant protein was induced at an OD 6 0 0 of approximately 0.6 by addition of isopropyl-β-D-thiogalactopyranoside (0.4 mM final concentration), and cultivation was continued for an additional 16 h at 16°C. Cells were harvested by centrifugation at 10,000 ×g, washed twice, and resuspended in Tris-HCl buffer (50 mM, pH 7.5). The resuspended cells were lysed by sonication in an ice-water bath with the ultrasonic processor VCX750 (Sonics & Materials Inc., USA), and centrifuged at 11,000 ×g for 30 min at 4 o C. The supernatant was applied to a HisTrap HP column (1 ml; GE Healthcare, USA) and the N-(His) 6 -tagged BmmGT1 protein was eluted with a linear gradient of imidazole (10-500 mM) in the binding buffer using a AKTA Purifier system. The purified proteins was desalted using the Ultrafree ®-4 Centrifugal Filter Unit (Millipore, Bedford, USA), and stored in Tris-HCl (50 mM, pH 8.0) buffer containing glycerol (10%) at -80 o C until use.
In Vitro Assays of BmmGT1
The substrate macrolactin A (1) was obtained from large-scale fermentation (20 L) of the ΔbmmGT1 mutant strain as previously described [13] . The concentration of BmmGT1 was determined by the Bradford method with bovine serum albumin as the standard.
To explore the catalytic capability of BmmGT1 at diverse reaction conditions, reaction mixtures (50 μl) consisting of compound 1 (0.2-1.0 mM), UDP-D-glucose (1.0-8.0 mM), BmmGT1 (0.2-12 μM), and MgCl 2 (10 μM) in Tris-HCl (50 mM, pH 8.9) were prepared, which were incubated at 30ºC for diverse reaction times (0.5-12 h) and quenched by addition of acetonitrile (50 μl). Then, the denatured protein was removed by centrifugation, and the supernatants were monitored by HPLC analysis with a YMC pack ODS-AQ column (5 mm, 150 × 4.6 mm; YMC Co., Japan) with UV detection at 260 nm. The in vitro assays of BmmGT1 with compounds 2 and 3 were performed in a reaction (50 μl) containing compound 2 or 3 (100 μM), UDP-D-glucose (1 mM), BmmGT1 (10 μM), MgCl 2 (10 μM), and Tris-HCl (50 mM, pH 8.9). The reaction mixtures were incubated at 30ºC for 2 h and quenched by addition of acetonitrile (50 μl). The supernatants were monitored by HPLC analysis with a YMC pack ODS-AQ C18 column (150 mm, 150 × 4.6 mm; 5 μm) with UV detection at 254 nm.
Isolation of Glycosylated Macrolactin Analogs
To isolate the compounds 1b−1e, large-scale reactions containing 8 μM of BmmGT1, 0.2 mM of 1, and 4 mM of UDP-D-glucose were performed, which were then purified on a semi-preparative HPLC YMC-Pack ODS-A C18 column (250 mm × 10 mm, i.d. 5 μm) with UV detection at 260 nm to afford 1b (0.8 mg), 1c (1.1 mg), 1d (1.1 mg), and 1e (1.3 mg), respectively.
Results and Discussion
The glycosyltransferase BmmGT1 from marine-derived B. methylotrophicus B-9987 was prepared by the method we described previously [13] . To explore the catalytic capability of BmmGT1, the enzymatic activities under diverse reaction conditions, including the reaction time and the working concentrations of the enzyme and substrate (1), were tested, followed by HPLC analysis. As shown in Fig. 2A , as the time was increased from 30 min to 1 h, the conversion rates increased from 48% to 53% and reached 100% at 2 h; the production of macrolactin B (1a) started to decrease at 4 h, and simultaneously, 1c, 1d, and 1b appeared successively. However, the substrate macrolactin A (1) reappeared at 12 h, indicating that the reverse reaction happened after a long incubation time. On the other hand, as the enzyme concentration was increased from 0.2 to 2 μM, 1c, 1d, and 1b appeared successively, in addition to 1a, and another glycosylated compound, 1e, appeared at a concentration of 4 μM and higher (Fig. 2B) . Under the conditions of 1 mM UDP-D-glucose and 8 μM BmmGT1, 0.2 mM of 1 was totally transformed into 1a, whereas 0.4 mM of 1 and above gave a 62% conversion rate (Fig. 2C) . Thus, 0.2 mM of 1 was adopted to probe the concentration of UDP-D-glucose, which revealed that when the concentration of UDP-Dglucose reached 4 mM, the majority of 1 was transformed into compounds with multiple sugar moieties (Fig. 2D) .
To determine the structure of the newly produced glycosylated macrolactins, a large-scale reaction was subsequently performed using the optimal conditions established above: 0. C) and 2D (COSY, HSQC, HMBC, and NOESY) NMR data assignment. The macrolactin ring of each compound was established by a combination of corresponding COSY, HSQC, and HMBC correlations. In the HMBC spectra of 1b-1e (Figs. S5, S10-S12), we observed the correlations from H-7 to the anomeric carbon C-1' for each compound, indicating a preference for 7-OH catalyzation of BmmGT1 towards macrolactin A (1). According to the HSQC spectrum of 1b, the NMR chemical shifts of H/C-13 and H/C-15 were almost identical to those of 1 [15] , revealing that the glucosyl unit was not located at these two positions. In the HMBC spectrum of 1b, we observed a correlation from H-3' (δ C NMR chemical shift values of 1c and 1d revealed that they were 7,15-di-O-β-D-glucosyl and 7,13-di-O-β-D-glucosyl macrolactin A analogs, respectively, which have been reported in our previous publication [14] . Except for the 7-O-glucosyl unit, 1e has two additional glucosyl units. In the 1 H NMR spectrum of 1e, the signals for the three glucosyl moieties overlapped severely; thus, the exact chemical shift values for each glucosyl unit in 1e were determined with the help of signal integration in the HSQC spectrum (Fig. 3A) . The HMBC correlations of H-13/C-1', H-1''/C-3'', and H-3''/C-1''' in 1e revealed that a 1→3-linked diglucosyl moiety was connected to 13-OH (Fig. 3B ).
All three of the anomeric protons of H-1' (δ C NMR chemical shift values of 1b and 1e are summarized in Table 1 .
To further investigate the aglycon promiscuity of BmmGT1, we probed the N-and S-glycosylation activities of BmmGT1 using 3,4-dichloroaniline (2) and 3,4-dichlorobenzenethiophenol (3) as acceptors [16] . As shown in Fig. 4 , BmmGT1 was able to recognize both compounds to generate N-glucosyl (2a) and S-glucosyl (3a and 3b) S (calcd. 502.0467) (Fig. S15) . According to the results of a SciFinder search, no diglucosylated analogs of 3 have been reported. Thus, 3b is speculated to be a new S-glucosyl analog, for which the linkage pattern of the two glucosyl units needs further 
determination.
Previously, we demonstrated that BmmGT1 prefers the 7-OH of macrolactins, and only acts on 13-OH or 15-OH, when 7-OH is not available [14] . Interestingly, by changing the reaction conditions, several glycosylated macrolactins with different sugar patterns were obtained. The timing of the appearances of 1a, 1c, and 1d clearly illustrates that the preference order for glycosyl transfer by BmmGT1 should be 7-OH > 13-OH > 15-OH. Although we obtained the 7,13-and 7,15-di-O-glycosylated analogs 1c and 1d, we did not obtain a 7,13,15-tri-O-glucosylated analog with any of the reaction conditions (Fig. 2) , whose generation might be inhibited by steric hindrance. The production of di/tri-Oglycosylated macrolactin analogs (1b and 1e), containing a glu-glu unit, indicated the potent capability of BmmGT1 for sugar-chain generation. Moreover, simple aromatics with the nucleophilic groups of -NH 2 and -SH were used for the enzymatic assays. Interestingly, BmmGT1 also exhibited N-and S-glycosylation activities toward 3,4-dichloroaniline (2) and 3,4-dichlorobenzenethiophenol (3), indicating that BmmGT1 has broad aglycon promiscuity. In summary, we have probed the aglycon promiscuity of the glycosyltransferase BmmGT1 from marine-derived B. methylotrophicus B-9987. The regioselectivity of BmmGT1 toward macrolactin A (1) was explored by optimization of the reaction conditions, which generated a series of O-glycosylated macrolactin analogs, including two new di/tri-O-glucosyl analogs (1b and 1e). In the investigation of the catalyzation capability of BmmGT1 toward unnatural phenolic compounds (2 and 3), the enzyme recognized both aglycons and generated N-(2a) or S-glycosides (3a and 3b), among which 3b was speculated to be a new di-Sglucosyl analog. The present study demonstrates that BmmGT1 could be used as a potential enzyme tool for the structural diversification of O-, N-, or S-glycosylated natural/ unnatural products.
